(Q34543842)

2 August 2017

title

Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma (English)

1 reference

malignant pheochromocytoma

2 August 2017

1 reference

1 reference

1 reference

1 reference

2

R Edward Coleman

1 reference

2 August 2017

Shawn D Safford

1

1 reference

2 August 2017

Jon P Gockerman

3

1 reference

2 August 2017

Joseph Moore

4

1 reference

2 August 2017

Jerome M Feldman

5

1 reference

2 August 2017

George S Leight

6

1 reference

2 August 2017

Douglas S Tyler

7

1 reference

2 August 2017

John A Olson

8

1 reference

2 August 2017

language of work or name

1 reference

1 December 2003

1 reference

2 August 2017

1 reference

2 August 2017

volume

134

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

956-62; discussion 962-3

1 reference

Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patients.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Long-term Results in 64 Patients Operated Upon for Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Scintigraphic Localization of Pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2803%2900426-4

7 January 2021

10.1016/S0039-6060(03)00426-4

Identifiers

DOI

1 reference

2 August 2017

1 reference